• Myasthenia gravis is an autoimmune disease which causes muscle weakness.
• The anti-acetylcholine receptor antibody causes a marked reduction of acetylcholine receptor density in the post-junctional membrane.
• There is a reduction in the safety margin for neuromuscular transmission which accounts for the fatiguable muscle weakness.
• Symptomatic improvement in muscle power can occur with anticholinesterase medication.
• Removal of the thymus gland often produces a reduction in anti-acetylcholine receptor antibody and an improvement in symptoms. Introduction
Myasthenia gravis is a disorder of neuromuscular transmission. The disease is brought about through the action of a circulating antibody which dramatically reduces the density of acetylcholine receptors on the postjunctional membrane of the neuromuscular junction ( New,s,om:iDavisii1992; Drachman 1994).
Was this article helpful?